Government, Alexion spar over Soliris

The Korean government and Alexion Pharmaceuticals, the drug maker that exclusively manufactures Soliris (eculizumab), are walking a tightrope not to irritate each other, but their conflicting needs continue to put them at odds over the possible supply of the drug.

Soliris is used to treat paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disease that affects a small population in Korea...